Liminatus Pharma, Inc. (LIMN)
0.864
+0.02
(+2.98%)
USD |
NASDAQ |
Dec 08, 16:00
0.8591
0.00 (0.00%)
After-Hours: 05:50
Liminatus Pharma Shareholders Equity (Quarterly): -1.646M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.278M |
| LENZ Therapeutics, Inc. | 193.93M |
| Oruka Therapeutics, Inc. | 486.79M |
| Maze Therapeutics, Inc. | 379.44M |
| MapLight Therapeutics, Inc. | 233.52M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.342M |
| Total Liabilities (Quarterly) | 2.988M |
| Debt to Equity Ratio | -0.8765 |
| Current Ratio | 0.4201 |
| Net Debt Paydown Yield | 1.03% |